Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines

R. E. Favoni, A. De Cupis, F. Ravera, C. Cantoni, P. Pirani, A. Ardizzoni, D. Noonan, R. Biassoni

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

In order to analyze the presence and the function of the 'insulin-like growth factor I (IGF-I) system' in human non-small-cell lung cancer (N-SCLC) we tested 5 cell lines of different histological sub-types: A549, Ca-Lu-6, SK-Lu-1 (adenocarcinoma); Ca-Lu-1, SK-Mes-1 (squamous carcinoma) and one normal fibroblast-like fetal lung cell line (IMR-90) for expression of the IGF-I peptide and its RNA transcribed from the IGF-I gene; IGF-binding proteins (IGF-BP); IGF-I receptor (IGF-I-R) and its mRNA. In addition, we examined the capacity of exogenous human recombinant IGF-I to enhance the in vitro cell proliferation. In medium conditioned from cell cultures, we detected immunoreactive IGF-I material by radioimmunoassay. Western ligand blot and affinity labelling demonstrated the presence of several molecular species of IGF-BPs (IGF-BP-4, -1, -2, -3) as well. Northern blot analysis of polyA+ RNA from all cell lines examined revealed the presence of IGF-I and IGF-I-R mRNA. Moreover, binding studies on cultured cell lines showed one class of high-affinity, operative type-1 IGF cell-surface binding sites. Finally, by thymidine uptake and colorimetric metabolic MTT assays, we found that most neoplastic cell lines react mitogenically to IGF-I and that its physiological effect is abolished by an anti-IGF-I-receptor antibody. These data indicate the importance of the IGF-I system in N-SCLC growth. Furthermore, they suggest that this mitogenic complex should be appraised as a possible target for anti-neoplastic drugs, antibodies or growth-factor analogues offering potential new approaches to therapy.

Original languageEnglish
Pages (from-to)858-866
Number of pages9
JournalInternational Journal of Cancer
Volume56
Issue number6
Publication statusPublished - 1994

Fingerprint

Insulin-Like Growth Factor I
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Cell Line
IGF Type 1 Receptor
Insulin-Like Growth Factor Binding Protein 4
RNA
Insulin-Like Growth Factor Binding Protein 1
Insulin-Like Growth Factor Binding Proteins
Messenger RNA
Antibodies
Conditioned Culture Medium
Northern Blotting
Thymidine
Radioimmunoassay
Squamous Cell Carcinoma
Cultured Cells
Intercellular Signaling Peptides and Proteins
Adenocarcinoma
Cell Culture Techniques

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines. / Favoni, R. E.; De Cupis, A.; Ravera, F.; Cantoni, C.; Pirani, P.; Ardizzoni, A.; Noonan, D.; Biassoni, R.

In: International Journal of Cancer, Vol. 56, No. 6, 1994, p. 858-866.

Research output: Contribution to journalArticle

@article{4f1dc489b1bd4700907cb2e6d31fbb46,
title = "Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines",
abstract = "In order to analyze the presence and the function of the 'insulin-like growth factor I (IGF-I) system' in human non-small-cell lung cancer (N-SCLC) we tested 5 cell lines of different histological sub-types: A549, Ca-Lu-6, SK-Lu-1 (adenocarcinoma); Ca-Lu-1, SK-Mes-1 (squamous carcinoma) and one normal fibroblast-like fetal lung cell line (IMR-90) for expression of the IGF-I peptide and its RNA transcribed from the IGF-I gene; IGF-binding proteins (IGF-BP); IGF-I receptor (IGF-I-R) and its mRNA. In addition, we examined the capacity of exogenous human recombinant IGF-I to enhance the in vitro cell proliferation. In medium conditioned from cell cultures, we detected immunoreactive IGF-I material by radioimmunoassay. Western ligand blot and affinity labelling demonstrated the presence of several molecular species of IGF-BPs (IGF-BP-4, -1, -2, -3) as well. Northern blot analysis of polyA+ RNA from all cell lines examined revealed the presence of IGF-I and IGF-I-R mRNA. Moreover, binding studies on cultured cell lines showed one class of high-affinity, operative type-1 IGF cell-surface binding sites. Finally, by thymidine uptake and colorimetric metabolic MTT assays, we found that most neoplastic cell lines react mitogenically to IGF-I and that its physiological effect is abolished by an anti-IGF-I-receptor antibody. These data indicate the importance of the IGF-I system in N-SCLC growth. Furthermore, they suggest that this mitogenic complex should be appraised as a possible target for anti-neoplastic drugs, antibodies or growth-factor analogues offering potential new approaches to therapy.",
author = "Favoni, {R. E.} and {De Cupis}, A. and F. Ravera and C. Cantoni and P. Pirani and A. Ardizzoni and D. Noonan and R. Biassoni",
year = "1994",
language = "English",
volume = "56",
pages = "858--866",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines

AU - Favoni, R. E.

AU - De Cupis, A.

AU - Ravera, F.

AU - Cantoni, C.

AU - Pirani, P.

AU - Ardizzoni, A.

AU - Noonan, D.

AU - Biassoni, R.

PY - 1994

Y1 - 1994

N2 - In order to analyze the presence and the function of the 'insulin-like growth factor I (IGF-I) system' in human non-small-cell lung cancer (N-SCLC) we tested 5 cell lines of different histological sub-types: A549, Ca-Lu-6, SK-Lu-1 (adenocarcinoma); Ca-Lu-1, SK-Mes-1 (squamous carcinoma) and one normal fibroblast-like fetal lung cell line (IMR-90) for expression of the IGF-I peptide and its RNA transcribed from the IGF-I gene; IGF-binding proteins (IGF-BP); IGF-I receptor (IGF-I-R) and its mRNA. In addition, we examined the capacity of exogenous human recombinant IGF-I to enhance the in vitro cell proliferation. In medium conditioned from cell cultures, we detected immunoreactive IGF-I material by radioimmunoassay. Western ligand blot and affinity labelling demonstrated the presence of several molecular species of IGF-BPs (IGF-BP-4, -1, -2, -3) as well. Northern blot analysis of polyA+ RNA from all cell lines examined revealed the presence of IGF-I and IGF-I-R mRNA. Moreover, binding studies on cultured cell lines showed one class of high-affinity, operative type-1 IGF cell-surface binding sites. Finally, by thymidine uptake and colorimetric metabolic MTT assays, we found that most neoplastic cell lines react mitogenically to IGF-I and that its physiological effect is abolished by an anti-IGF-I-receptor antibody. These data indicate the importance of the IGF-I system in N-SCLC growth. Furthermore, they suggest that this mitogenic complex should be appraised as a possible target for anti-neoplastic drugs, antibodies or growth-factor analogues offering potential new approaches to therapy.

AB - In order to analyze the presence and the function of the 'insulin-like growth factor I (IGF-I) system' in human non-small-cell lung cancer (N-SCLC) we tested 5 cell lines of different histological sub-types: A549, Ca-Lu-6, SK-Lu-1 (adenocarcinoma); Ca-Lu-1, SK-Mes-1 (squamous carcinoma) and one normal fibroblast-like fetal lung cell line (IMR-90) for expression of the IGF-I peptide and its RNA transcribed from the IGF-I gene; IGF-binding proteins (IGF-BP); IGF-I receptor (IGF-I-R) and its mRNA. In addition, we examined the capacity of exogenous human recombinant IGF-I to enhance the in vitro cell proliferation. In medium conditioned from cell cultures, we detected immunoreactive IGF-I material by radioimmunoassay. Western ligand blot and affinity labelling demonstrated the presence of several molecular species of IGF-BPs (IGF-BP-4, -1, -2, -3) as well. Northern blot analysis of polyA+ RNA from all cell lines examined revealed the presence of IGF-I and IGF-I-R mRNA. Moreover, binding studies on cultured cell lines showed one class of high-affinity, operative type-1 IGF cell-surface binding sites. Finally, by thymidine uptake and colorimetric metabolic MTT assays, we found that most neoplastic cell lines react mitogenically to IGF-I and that its physiological effect is abolished by an anti-IGF-I-receptor antibody. These data indicate the importance of the IGF-I system in N-SCLC growth. Furthermore, they suggest that this mitogenic complex should be appraised as a possible target for anti-neoplastic drugs, antibodies or growth-factor analogues offering potential new approaches to therapy.

UR - http://www.scopus.com/inward/record.url?scp=0028293446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028293446&partnerID=8YFLogxK

M3 - Article

C2 - 7509779

AN - SCOPUS:0028293446

VL - 56

SP - 858

EP - 866

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -